TRIM56 and infection: This antiviral barrier property, as shown in cell culture infection models, does not stem from general augmentation of IFN response, a conclusion also supported by the observations that TRIM56 does not restrict vesicular stomatitis virus (VSV, a Rhabdoviridae member) [29,31] or HCV [31].